DANSK BIOTEK organizes four major plenary meetings for our members throughout the year to increase our members' knowledge regarding specific biotech topics and to facilitate networking. The events usually take place in February, May, September and November.

We also organize approximately six "saloon" meetings annually. They are small, intimate, "meet the expert" meetings with typically 6-20 participants advocating more in-depth discussion and knowledge-sharing on specific themes.

09 Nov 2015

Onxeo har succesfulde fase 1-data med kræftmiddel

MedWatch rapporterer:

Onxeo har haft succes i et fase 1-studie med selskabets kræftmiddel Belinostat som første-linje-behandling i patienter med lymfekræftformen perifert T-celle lymfom, PTCL.

I studiet blev Belinostat, der i forvejen er godkendt i USA som andenbehandling af PTCL, givet i kombination med førstelinjebehandlingen, kemoterapiformen, CHOP, der består af stofferne Cyclophosphamid, Doxorubicin, Vincristin og Prednisolon.

If you can't find it here or have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2015 Danskbiotek. All rights reserved.